Ibrutinib Treatment for First-Line and Relapsed/ Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase Ib/II PCYC-1102 Study

John C. Byrd, Richard R. Furman, Steven E. Coutre, Ian W. Flinn, Jan A. Burger, Kristie Blum, Jeff P. Sharman, William Wierda, Weiqiang Zhao, Nyla A. Heerema, Ying Luan, Emily A. Liu, James P. Dean, Susan O’Brien

Research output: Contribution to journal › Article › peer-review

125 Scopus citations

Fingerprint

Dive into the research topics of 'Ibrutinib Treatment for First-Line and Relapsed/ Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase Ib/II PCYC-1102 Study'. Together they form a unique fingerprint.

Medicine & Life Sciences